Fertility Preservation Before Cancer Treatment

For women diagnosed with cancer, fertility preservation has become an increasingly important aspect of care. At Arda Lembet’s clinic, protective reproductive strategies are offered before starting chemotherapy—especially in cases of breast cancer or hematologic malignancies.

Timeline and Options Before Treatment

There is typically a 6-week window before chemotherapy begins. During this period, three primary fertility preservation methods can be considered:

  • Embryo cryopreservation: If the patient is married, eggs are fertilized with the partner’s sperm to create embryos, which are then frozen.
  • Oocyte cryopreservation (egg freezing): For young or unmarried women, eggs are retrieved and frozen without fertilization.
  • Ovarian tissue cryopreservation: A portion of the ovary containing primordial follicles is surgically removed and stored.

Among these, embryo freezing is the most established and well-studied. Egg and ovarian tissue freezing were once considered experimental, but advances in vitrification (ultra-rapid freezing) have made them more effective and widely adopted.

Breast Cancer and Fertility Preservation

Breast cancer is the most common cancer among reproductive-aged women, with 15% of cases occurring in women under 40. Today, the success rate of treatment has improved significantly, with 5-year survival rates approaching 90%.

However, chemotherapy can permanently damage ovarian tissue and reduce egg reserves. The risk of premature ovarian failure (early menopause) increases significantly after age 35.

Therefore, the treatment plan must now consider not only cancer survival but also the woman’s quality of life and future fertility potential.

Our Protocol and Workflow

Before treatment begins, ovarian reserve is first assessed. During the 6-week window following surgery or diagnosis, the following steps are taken:

  • If the woman is married, eggs are fertilized with her partner’s sperm and embryos are frozen.
  • If she is unmarried, eggs are retrieved and frozen unfertilized.
  • If there is not enough time for egg retrieval, ovarian tissue is surgically removed and frozen.
  • In vitro maturation (IVM) may also be used to mature eggs in the lab without raising estrogen levels, which is particularly important in hormone-sensitive cancers like breast cancer.

Note that once chemotherapy has begun, fertility preservation is no longer feasible. Chemotherapy significantly impairs ovarian function. That is why planning before treatment begins is critical.

Frequently Asked Questions

Is This Method New?

Embryo freezing has been used for many years. Egg freezing, however, has become more widely adopted more recently. While slow freezing techniques were used in the past, vitrification (ultra-rapid freezing) is now the standard, offering significantly higher success rates.

Is the Process the Same for All Types of Cancer?

The process is similar in most cancers. In addition to breast cancer, similar fertility preservation methods are used in hematologic cancers such as leukemia and lymphoma. The primary goal is to protect ovarian reserve before chemotherapy begins.

Can Fertility Treatment Be Done After Chemotherapy?

No. Chemotherapy significantly damages ovarian reserve. Even if a woman continues to have menstrual periods, her chances of achieving pregnancy are greatly reduced.

What If There Isn’t Enough Time?

If the procedure cannot be completed within the 6-week window, ovarian tissue cryopreservation becomes an option. The tissue can later be thawed and transplanted back into the body. However, this method is still considered experimental.

Are These Procedures Risky?

Some cancers are hormone-sensitive—for example, breast cancer is sensitive to estrogen. Since medications used to stimulate the ovaries can raise estrogen levels, this risk is minimized through careful selection of medications. There are also safe protocols that allow for egg retrieval without increasing estrogen levels.

1